The Long-Term Impact of Postoperative Educational Programs on Weight Loss After Roux-en-Y Gastric Bypass.


Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
09 2022
Historique:
received: 29 04 2022
accepted: 27 06 2022
revised: 25 06 2022
pubmed: 6 7 2022
medline: 24 8 2022
entrez: 5 7 2022
Statut: ppublish

Résumé

Roux-en-Y gastric bypass (RYGB) is a well-documented treatment of severe obesity. Attending postoperative educational programs may improve the outcome. The aim of this study was to evaluate whether participation in educational programs lasting 2-3 years after RYGB influences long-term weight loss, weight regain, physical activity, and compliance to multivitamin supplements. The Bariatric Surgery Observation Study (BAROBS) is a multicenter retrospective, cross-sectional study 10-15 years after primary RYGB. Four hundred and ninety-seven participants answered questions regarding participation in postoperative educational programs. Participants were divided into frequent attendees (FA) and infrequent attendees (IFA) at the educational programs. Ten to 15 years after surgery, a total weight loss (TWL) of 23.2 ± 11.6% were seen in the FA group vs 19.5 ± 12.6% in the IFA group, p < 0.001. Percent excess weight loss (%EWL) was 55.7 ± 28.9% vs 46.0 ± 31.1%, p < 0.001. Weight regain in percent of maximal weight loss for the FA was 32.1 ± 32.8% vs IFA 38.4 ± 40.0%, p = 0.052. No difference between the groups in compliance to multivitamin and physical activity. Participants with frequent participation in group-based educational programs had better weight loss outcomes 10-15 years after RYGB and tended to have less weight regain. There was no difference between the two groups in participants compliance to recommended multivitamin supplements and physical activity.

Identifiants

pubmed: 35790673
doi: 10.1007/s11695-022-06187-6
pii: 10.1007/s11695-022-06187-6
pmc: PMC9392699
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3005-3012

Informations de copyright

© 2022. The Author(s).

Références

N Engl J Med. 2022 Feb 24;386(8):768-779
pubmed: 35196429
Obes Surg. 2021 Jun;31(6):2520-2528
pubmed: 33624212
Obes Res Clin Pract. 2022 Mar-Apr;16(2):163-169
pubmed: 35393266
Med Sci Sports Exerc. 2009 Feb;41(2):459-71
pubmed: 19127177
J Visc Surg. 2022 Aug;159(4):298-308
pubmed: 35304081
JAMA Surg. 2018 May 1;153(5):427-434
pubmed: 29214306
Obes Surg. 2005 Aug;15(7):1066-9
pubmed: 16105409
Obes Surg. 2019 Oct;29(10):3385-3400
pubmed: 31367987
Obes Surg. 2021 Jun;31(6):2701-2708
pubmed: 33796974
Obes Surg. 2021 May;31(5):1979-1985
pubmed: 33428161
Obes Surg. 2021 Mar;31(3):1290-1303
pubmed: 33392999
Surg Obes Relat Dis. 2022 Jun;18(6):747-754
pubmed: 35361539
Lancet. 2009 Mar 28;373(9669):1083-96
pubmed: 19299006
Obesity (Silver Spring). 2020 Apr;28(4):O1-O58
pubmed: 32202076
Surg Obes Relat Dis. 2018 Jul;14(7):910-917
pubmed: 29706496
JAMA. 2018 Oct 16;320(15):1560-1569
pubmed: 30326125
Obes Rev. 2017 Mar;18(3):317-334
pubmed: 28170168
Surg Obes Relat Dis. 2018 Jul;14(7):1033-1040
pubmed: 29778650
Obes Surg. 2003 Jun;13(3):364-70
pubmed: 12841895
Obes Surg. 2017 May;27(5):1316-1323
pubmed: 27914028
Surg Obes Relat Dis. 2015 May-Jun;11(3):489-506
pubmed: 26093765
Obes Surg. 2020 Jun;30(6):2118-2123
pubmed: 32030615
Obes Surg. 2019 Jan;29(1):3-14
pubmed: 30293134

Auteurs

Kirsti K Bjerkan (KK)

Faculty of Social Science and History, Volda University College, Joplassvegen 1, 6103, Volda, Norway. kirsti.kverndokk.bjerkan@hivolda.no.
Department of Surgery, Møre and Romsdal Hospital Trust, Ålesund Hospital, Ålesund, Norway. kirsti.kverndokk.bjerkan@hivolda.no.

Jorunn Sandvik (J)

Department of Surgery, Møre and Romsdal Hospital Trust, Ålesund Hospital, Ålesund, Norway.
Centre for Obesity and Innovation (ObeCe), Clinic of Surgery, St. Olav University Hospital, Trondheim, Norway.

Siren Nymo (S)

Centre for Obesity and Innovation (ObeCe), Clinic of Surgery, St. Olav University Hospital, Trondheim, Norway.
Obesity Research Group, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Nord-Trøndelag Hospital Trust, Clinic of Surgery, Namsos Hospital, Namsos, Norway.

Hallvard Græslie (H)

Nord-Trøndelag Hospital Trust, Clinic of Surgery, Namsos Hospital, Namsos, Norway.

Gjermund Johnsen (G)

Obesity Research Group, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Norwegian National Advisory Unit On Advanced Laparoscopic Surgery, Clinic of Surgery, St. Olav's University Hospital, Trondheim, Norway.

Ronald Mårvik (R)

Obesity Research Group, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Norwegian National Advisory Unit On Advanced Laparoscopic Surgery, Clinic of Surgery, St. Olav's University Hospital, Trondheim, Norway.

Åsne A Hyldmo (ÅA)

Centre for Obesity and Innovation (ObeCe), Clinic of Surgery, St. Olav University Hospital, Trondheim, Norway.

Bård Eirik Kulseng (BE)

Obesity Research Group, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.

Kjetil Laurits Høydal (KL)

Department of Physical Education, Volda University College, Volda, Norway.

Dag Arne L Hoff (DAL)

Department of Research and Innovation, Møre and Romsdal Hospital Trust, Ålesund, Norway.
Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Trondheim, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH